- About BME
- Academics Home
- Combined Degrees
- Student Resources
- Industry Home
- Partner Benefits
- Student Design Projects
- Guest Lectures
- BME Interns
- Research Collaborations
- Tech Licensing
- Industry News
- "Women's Radio Network Open Forum" To Feature AxoGen, Inc.
- 3rd Annual Pruitt Research Day
- AxoGen, Inc. Announces Clearance from FDA to Proceed with New Multicenter Comparative Study for Avance® Nerve Graft
- AxoGen, Inc. Announces Completion of a Pilot Clinical Study Assessing Cavernous Nerve Reconstruction with Avance® Nerve Graft
- BioD LLC Makes $1 Million Gift Commitment to UF BME
- BioD Receives U.S. Patent for Unique Placental Tissue Technology
- Dr. Peter McFetridge awarded the Tim Brahm Professorship
- Event Celebrates BioD’s $1 Million Gift to BME
- New Industry Partner: Sigma Aldrich Corporation
- RTI Surgical™ Announces Agreement With Novation
- Record BME Industry Partner Participation at the 4th Annual Pruitt Research Day
- SPECIAL EVENT: “Geraldo Rivera Show” to Feature AxoGen, Inc.
- Stryker Provides Guest Lecture to BME Students
- Contact Us
Cherie Stabler, Ph.D.
Cherie Stabler, Ph.D.
Associate Professor & Associate Chair for Graduate Studies
Biomaterials, controlled release, regenerative medicine & diabetes
1275 Center Drive, Biomedical Sciences Building J385, Gainesville, FL 32611
B.S., Chemical Engineering, The Florida State University and Florida A&M University, 1998
Ph.D., Biomedical Engineering, The Georgia Institute of Technology & Emory University, 2004
Dr. Stabler’s research centers on engineering translational biomaterial platforms for cell-based therapies, particularly Type 1 diabetes. Specifically, her research seeks to develop bioactive materials capable of: protecting cells from immunological attack; providing 3-D support of the transplanted cells; presenting cues for guiding positive host cell remodeling; and releasing therapeutic agents. Through the fabrication of novel biomaterials capable of actively interfacing with the host, she seeks to optimize the graft environment to favor the long-term survival and function of the implanted cells.
Honors and Awards:
- Bioengineering, Technology, and Surgical Sciences Study Section, NIH Center for Scientific Review, 2016
- University of Miami, College of Engineering, Johnson A. Edosomwan Researcher of the Year, 2011
- University of Miami, College of Engineering, Eliahu I. Jury Early Career Research Award, 2009
- National Institutes of Health NIDDK Type 1 Diabetes Pathfinder Award, 2008
- Most-Cited Article of the Year, Bioconjugate Chemistry (American Chemical Society), 2006
- Juvenile Diabetes Research Foundation Individual Postdoctoral Fellowship, 2005
- NIH Ruth L. Kirschstein National Research Service Award Individual Postdoctoral Fellowship (Declined in lieu of JDRF Fellowship), 2005
Weaver, JD, and Stabler, CL, Antioxidant Cerium Oxide Nanoparticle Hydrogels for Cellular Encapsulation, Acta Biomaterialia, Apr; 16, pp 136-44 (2015)
Rengifo, HR, Giraldo, JA, Labrada, I, and Stabler, CL, Long-term Survival of Allograft Murine Islets Coated via Covalently Stabilized Polymers, Advanced Healthcare Materials, 3 (7), pp 1061-70 (2014).
Gattás-Asfura, KM, and Stabler, CL, Bioorthogonal Layer-by-layer Encapsulation of Pancreatic Islets via Hyperbranched Polymers, ACS Applied Materials & Interfaces, 5 (20), pp 9964–9974 (2013)
Brady, A-C, Martino, MM, Pedraza, E, Sukert, S, Pileggi, A, Ricordi, C, Hubbell, JA, and Stabler, CL, Modulated Release of Pro-Angiogenic Factors within Macroporous Scaffolds Enhances Islet Engraftment in an Extrahepatic Site, Tissue Engineering, 19 (23-24), pp. 2544-52, (2013).
Pedraza, E. , Coronel, MM, Fraker, CA, Ricordi, C, and Stabler, CL, Preventing hypoxia-induced cell death in beta cells and islets via hydrolytically activated, oxygen-generating biomaterials, Proceedings of the National Academy of Sciences of the United States of America, 109(11) pp. 4245-50 (2012).